What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Diabetes mellitus
His primary areas of study are Internal medicine, Endocrinology, Insulin, Insulin resistance and Carbohydrate metabolism.
His work deals with themes such as Somatropin, Metabolism and Growth hormone deficiency, which intersect with Insulin.
Niels Møller interconnects C-peptide and Type 2 diabetes in the investigation of issues within Insulin resistance.
Niels Møller focuses mostly in the field of C-peptide, narrowing it down to matters related to Impaired glucose tolerance and, in some cases, Global health.
The Carbohydrate metabolism study combines topics in areas such as Anabolism, Lipid metabolism, Resting energy expenditure and Glucagon-like peptide-1.
His research investigates the connection between Diabetes mellitus and topics such as Epidemiology that intersect with problems in Gerontology and Body mass index.
His most cited work include:
- Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants (2278 citations)
- Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults (2180 citations)
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants (1737 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Insulin, Insulin resistance and Lipolysis.
His Internal medicine study frequently links to related topics such as Diabetes mellitus.
All of his Endocrinology and Carbohydrate metabolism, Metabolism, Glucose uptake, Skeletal muscle and Adipose tissue investigations are sub-components of the entire Endocrinology study.
His study in the field of Pancreatic hormone also crosses realms of Lipid oxidation.
His research on Insulin resistance concerns the broader Obesity.
His Lipolysis research is multidisciplinary, relying on both Lipid metabolism, Protein catabolism, Crossover study and Ghrelin.
He most often published in these fields:
- Internal medicine (91.46%)
- Endocrinology (86.41%)
- Insulin (36.12%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (91.46%)
- Endocrinology (86.41%)
- Insulin resistance (28.16%)
In recent papers he was focusing on the following fields of study:
Niels Møller mostly deals with Internal medicine, Endocrinology, Insulin resistance, Insulin and Lipolysis.
His study in Internal medicine is interdisciplinary in nature, drawing from both Diabetes mellitus and Type 2 diabetes.
As part of the same scientific family, Niels Møller usually focuses on Endocrinology, concentrating on Crossover study and intersecting with Phenylalanine.
Niels Møller combines subjects such as Glucagon, Blood pressure and Growth hormone with his study of Insulin resistance.
His Insulin study incorporates themes from Hormone, Carbohydrate metabolism and Ketosis.
His work in the fields of Lipolysis, such as Acipimox, overlaps with other areas such as Lipid oxidation.
Between 2017 and 2021, his most popular works were:
- Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients (78 citations)
- Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients (78 citations)
- A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects (76 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Endocrinology
Niels Møller mainly focuses on Internal medicine, Endocrinology, Insulin resistance, Ketone bodies and Lipid metabolism.
His Internal medicine research integrates issues from Depression and Cardiology.
His Endocrinology study combines topics from a wide range of disciplines, such as Inflammation and mTORC1.
His research integrates issues of Adipose tissue, Lipolysis, Glucagon and Growth hormone in his study of Insulin resistance.
His biological study spans a wide range of topics, including Diabetes mellitus, Positron emission tomography and Ejection fraction, Heart failure.
His work on Glucose uptake as part of general Insulin study is frequently connected to Nicotinamide riboside, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
